Little is known about the relationship between insulin resistance and proliferative diabetic retinopathy in type 1 diabetes. The aim of this article is to explore the relationship between sight-threatening proliferative diabetic retinopathy and insulin resistance.
INTRODUCTION
With 70-100% of patients being affected, retinopathy is the most common type 1 diabetes (T1D) complication [1] .
Diabetic retinopathy lesions are divided into two large categories: nonproliferative (NPDR) and proliferative (PDR). Almost all T1D patients have NPDR. The more severe form of retinopathy, PDR, affects 15-50% of T1D patients over 15-20 years of disease duration [2, 3] . It usually progresses to visual impairment. In developed countries diabetic retinopathy is the main cause of blindness in working age group [4] . Identifying patients at risk of ocular impairment is a concern for clinicians.
Elements of metabolic syndrome such as hyperglycemia [5] [6] [7] , hypertension [8] , dyslipidemia [9, 10] and abdominal obesity [10] are known to be risk factors for the occurrence of diabetic retinopathy. Insulin resistance is the physio-pathological substrate for the metabolic syndrome. Insulin resistance is a key element in the pathogenesis of T2D. It has been suggested that insulin resistance is also present in T1D. It appears that in T1D patients insulin resistance is an independent risk factor for micro-(nephropathy, neuropathy and retinopathy) and macro-(coronary artery disease and peripheral vascular disease) vascular complications [11] [12] [13] [14] [15] .
The purpose of this article was to assess insulin resistance in T1D patients stratified according to the presence or absence of PDR. For our secondary aim we hypothesized that in T1D patients insulin resistance, quantified using the estimated glucose disposal rate (eGDR) formula, would be associated with PDR.
MATERIALS AND METHODS
Study design was cross-sectional. We included patients with type 1 diabetes who underwent medical checkups in "N.C. Paulescu" Institute during a one year period (from January to December 2012). A total of 167 patients with type 1 diabetes were included in the study.
Inclusion criteria. Type 1 diabetes mellitus was defined as: diabetes onset before the age of 35 years with permanent insulin treatment initiated within the first year after diagnosis. Eligibility for inclusion in the study was based on the clinical diagnosis of type 1 diabetes. Confirmation, by determining serum C peptide level (< 0.3 nmol/l), was available only for the subset of patients in which there were doubts regarding T1D diagnosis. The study included either patients with chronic kidney disease stages 4 (urinary albumin excretion rate -AER > 300 mg/24h) and 5 (end stage renal disease -predialysis/dialysis/renal transplant) according to Mogensen classification or patients with at least 15 years duration of diabetes, eGFR (estimated glomerular filtration rate) between 90-130 ml/min/1.73 m 2 and AER < 30 mg/24h. T1D patients that had AER = 30-300 mg/24 h and any other condition that might interfere with albumin excretion (hyperglycaemia, uncontrolled hypertension, heart failure or urinary tract infection) were re-examined.
Exclusion criteria. Patients were excluded from the study in the case of any doubt about type 1 diabetes diagnosis (even after determining the serum C peptide level) or if any evidence of nondiabetic renal disease.
Patients were stratified according to the presence or absence of PDR.
Clinical parameters. Registration of: diabetesrelated data, anthropometric indices, blood pressure, smoking status, alcohol intake, family history, diabetes-related complications data was done. Supine systolic (SBP) and diastolic (DBP) blood pressure was measured in both arms after 10 minutes of rest. We used the arithmetic mean of the values obtained. Hypertension was defined as a BP> 140/90 mm Hg and/or use of antihypertensive treatment.
Laboratory parameters. Fasting blood samples were collected for assessment of HbA1c (glycated hemoglobin), C-peptide, fasting glucose, lipids (total cholesterol, HDL cholesterol, triglycerides) and serum creatinine. HbA1c level was measured by a standardized DCCT (Diabetes Control and Complications Trial) method. C-peptide levels were measured using an ELISA technique. Glucose, lipids and creatinine and were assessed using enzymatic methods. The glomerular filtration rate was estimated using the CKD-EPI formula (Chronic Kidney Disease Epidemiology Collaboration). Urine samples were collected in order to determine AER/24 h.
Assessment of insulin resistance. Insulin resistance was assessed using the eGDR formula. eGDR is an equation derived from hyperinsulinemic euglycemic clamp studies [16] . eGDR (ml/kg/min) is based on clinical parameters and is calculated as follows: eGDR = 24.31 -(12.22 x WHR) -(3.29 X BP) -(0.57 X HbA1C), where WHR -waist to hip ratio, BP -history of hypertension (yes = 1, no = 0), HbA1c -glycated hemoglobin A1C.
Assessment of diabetic retinopathy. Retinopathy was assessed following ophthalmological examination. The eye with the most severe involvement was used for categorization of ocular involvement. Early Treatment Diabetic Retinopathy Study classification was used to assess the severity of retinopathy. NPDR was diagnosed if any of microaneurysms, hemorrhages, hard exudates, venous congestion, cotton wool spots or intraretinal micovascular abnormalities were present. PDR was registered when new vessels, glial proliferation, preretinal hemorrhage, vitreous hemorrhage, scars of photocoagulation (known to have been directed at new vessels) and/or retinal detachment were found. Patients with none of these abnormalities were classified as not having retinopathy.
Ethical considerations. Patient enrollment complied with the Declaration of Helsinki. The study was approved by the local ethics committee.
Statistical analysis.Continuous variables with normal distribution are presented as mean ± SD. Continuous variables with non-normal distribution are presented as median and interquartile range.The distribution of continuous variables was tested for normality using Kolmogorov-Smirnov and ShapiroWilk tests. Categorical variables are presented as frequencies (%). Between-group comparisons were made using Student's t test (for normally distributed variables), Mann-Whitney U test (for non-normally distributed variables) and χ2 test (for categorical variables).
The association between insulin resistance (quantified using eGDR) and PDR was assessed in uni and multivariate logistic regression models.
Initially, we analyzed the association between eGDR and PDR in univariate logistic regression models and then regression was adjusted for duration of diabetes and sex.
To assess the contribution of insulin resistance (quantified using eGDR) and potential confounders to PDR we conducted a multivariate analysis (logistic regression) where the dependent variable was the appearance of PDR (noted as presence / absence) and the independent variables are the risk factors studied (eGDR, sex, duration of diabetes, BMI, HDL cholesterol, LDL cholesterol, triglycerides and smoking status). Backward stepwise procedure was used. Statistical analyses were performed using SPSS version 20.0. P-values < 0.05 were considered statistically significant. Variables that did not meet this criterion were removed from the model. The contribution of individual predictors in the final regression model was examined using Wald statistic.
RESULTS

Characteristics of patients.
The study included 167 patients with type 1 diabetes (108 men and 59 women). General characteristics of the studied population are presented elsewhere [17] . A total of 43.11% (n = 72) of patients from the targeted group were free of ocular damage; 18.57% (n = 31) had NPDR and 38.32% (n = 64) had PDR. The prevalence of hypertension was significantly higher in the group with PDR (75% vs 48.5%; p = 0.001). There were no differences between groups regarding the prevalence of dyslipidemia (p = 0.25) or smoking (p = 0.58).
Patients with PDR had significant differences regarding parameters that assess kidney function: AER (358.5 vs 3.7 mg/24 h; p < 0.001) and eGFR PDR group had significantly lower eGDR's value (5.5 vs 7 mg/kg/min; p = 0.002). Characteristics of patients with PDR are presented in Table 1 .
eGDR: univariate and multivariate analysis. In univariate analysis PDR was significantly associated with eGDR (OR = 0.78; p = 0.002). The association remained significant after adjustment for sex and duration of diabetes (OR = 0.78; p = 0.003).
In the multivariate analysis eGDR was one of the variables retained in the model (OR = 0.73; p <0.001) and it was the parameter most strongly associated with PDR (Wald = 12.73). BMI was also retained in the regression model (OR= 0.88; p = 0.013 ).
The following variables were rejected from the model (p > 0.05): sex, duration of diabetes, LDL cholesterol, HDL cholesterol, triglycerides and smoking. The uni and multivariate analysis results are presented in Table 2 . Normally distributed variables: mean ± SD; * Non-normally distributed variables: median ± interquartile range; Categorical variables: percents.
PDR -proliferative diabetic retinopathy; BMI -Body Mass Index; WHR -waist-hip ratio; SBP -systolic blood pressure; DBP -diastolic blood pressure; HbA1c -glycated hemoglobin; eGDR -estimated glucose disposal rate; LDL -low density lipoprotein cholesterol; HDL -high density lipoprotein; AER-urinary albumin excretion rate; eGFR -estimated glomerular filtration rate. 
DISCUSSION
The main finding of the study is that insulin resistance, assessed using eGDR, is a characteristic of patients with PDR (OR = 0.78; p = 0.002). A low eGDR's value, suggestive of high insulin resistance, was independently (of sex, duration of diabetes, BMI, LDL cholesterol, HDL cholesterol, triglycerides, smoking status) associated with PDR (OR = 0.73; p < 0.001).
Although in T2D some studies have found an association between decreased insulin sensitivity and diabetic retinopathy [18, 19] in T1DM additional studies would be needed to clarify this issue. In type 1 diabetes the study of the association insulin sensitivity -diabetic retinopathy has been based on two observations: adolescents with type 1 diabetes are more insulin-resistant than non-diabetic controls [20] and puberty is characterized by an accelerated evolution towards retinopathy [21] [22] [23] . In the Finn Diane study the risk of PDR onset was, after adjustment for metabolic control (HbA1c) and BP, 1.8 times higher in those with diabetes onset before the age of 15 compared to those post-pubertal onset of disease (15-40 years) [21] . After four years of follow-up in WESDR study (The Wisconsin Epidemiologic of Diabetic Retinopathy), the highest incidence of retinopathy was in the 10-12 years old age group of patients [22] . Other studies described a long time from diabetes diagnosis to complications in adolescents diagnosed before puberty compared with those diagnosed after this period [23] .
These evidence suggest that in type 1 diabetes elevated insulin sensitivity is associated with lower risk of diabetic retinopathy and proliferative retinopathy.
Moreover in the DCCT study insulin resistance, quantified using eGDR, but neither insulin dose nor metabolic syndrome, was an independent risk factor (of age, sex, duration of diabetes, glycemic control and prevention cohort) for the development and progression of retinopathy [14] . In the EURO-DIAB Prospective Complications Study markers such as triglycerides or WHR, suggestive for a low insulin-sensitivity, have been associated with increased incidence of retinopathy and proliferative retinopathy [10] . In a recent analysis Pop et al. found that a low eGDR's value was significantly associated with PDR [24] .
These studies suggest that an elevated eGDR value, suggestive of insulin sensitivity, is associated with a lower risk of diabetic retinopathy.Our results confirm and extend previous observations, showing in addition that insulin resistance (assessed using eGDR) would be the most important risk factor for PDR.
BMI was one of the variables retained in the final regression model (OR = 0.88; p = 0.013) -a low BMI was associated with PDR. It is known that the severity of the retinopathy is associated with the severity of renal morphological changes [25] and also with the severity of clinical nephropathy [26] . This data suggest that PDR would be associated with wasting syndrome due to nephropathy. These findings are in accordance with other studies [27] [28] [29] . These observations are side findings and were not the purpose of current study.
Sex, duration of diabetes, lipid profile components and smoking were among the risk factors excluded from the models after the selection of the most important covariates for PDR. A possible explanation of these observations could be a cohort with an insufficient number of patients in order to achieve statistical significance for the variables mentioned above. A good management of modifiable risk factors such as lipid profile and smoking could be another explanation for the decline in the strength of these risk factors. A third possibility would be that eGDR's formula captures other risk factors such as lipid profile components. Another possibility would be that insulin resistance (measured using eGDR) would be the most important risk factor, independent of sex, duration of diabetes lipid profile or smoking.
CONCLUSIONS
Our findings suggest that in type 1 diabetes insulin resistance was the most important risk factor asociated with PDR. Early screening for insulin resistance may identify high risk patients who may benefit the most from preventive and therapeutic interventions.
